Detalhe da pesquisa
1.
A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome.
Ann Oncol
; 22(7): 1608-1613, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21252059
2.
Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma.
Ann Oncol
; 19(5): 964-9, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18296419
3.
(90)Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma.
Bone Marrow Transplant
; 46(12): 1503-9, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21258420
4.
A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma.
Leukemia
; 25(2): 341-7, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21135857
5.
G-CSF plus plerixafor (Mozobil) to mobilize hematopoietic stem cells in patients with thrombocytopenia or leukopenia prior to auto-SCT.
Bone Marrow Transplant
; 48(2): 303-4, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22773123